AptaBio Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	18,754	25,542	25,016	1,989
Short-Term Investments	1,052	1,020	19,000	15,026
Trading Asset Securities	-	4,954	8,869	-
Cash & Short-Term Investments	19,806	31,515	52,885	17,015
Cash Growth	-47.86%	-40.41%	210.81%	-
Accounts Receivable	1,335	893.71	-	-
Other Receivables	241.5	238.05	366.31	224.46
Receivables	1,771	1,435	2,659	3,047
Inventory	558.77	224.87	-	-
Prepaid Expenses	96.51	212.04	176.31	88.23
Other Current Assets	1,342	1,548	1,754	268.93
Total Current Assets	23,574	34,935	57,474	20,419
Property, Plant & Equipment	5,958	4,962	5,129	5,848
Long-Term Investments	30,316	30,986	23,779	27,885
Other Intangible Assets	29.8	39.35	61.09	37.83
Other Long-Term Assets	2,846	3,611	3,675	1,924
Total Assets	67,120	77,434	92,519	56,114
Accounts Payable	53.26	1.87	-	-
Accrued Expenses	645.26	609.79	337.19	455.54
Short-Term Debt	8,791	7,244	-	-
Current Portion of Leases	176.49	154.6	131.08	109.73
Current Income Taxes Payable	-	-	1.48	-
Other Current Liabilities	8,885	11,529	348.2	474.75
Total Current Liabilities	18,551	19,540	817.95	1,040
Long-Term Debt	-	-	13,569	-
Long-Term Leases	56.83	122.01	233.45	256.3
Pension & Post-Retirement Benefits	3,813	3,503	3,011	2,393
Other Long-Term Liabilities	86.52	71.4	13,524	54.58
Total Liabilities	22,507	23,237	31,156	3,744
Common Stock	13,441	13,441	11,149	11,149
Additional Paid-In Capital	149,733	149,733	129,712	109,025
Retained Earnings	-119,986	-110,112	-80,713	-68,473
Comprehensive Income & Other	1,425	1,135	696.37	668.63
Total Common Equity	44,613	54,197	60,845	52,370
Shareholders' Equity	44,613	54,197	61,363	52,370
Total Liabilities & Equity	67,120	77,434	92,519	56,114
Total Debt	9,024	7,521	13,934	366.03
Net Cash (Debt)	10,782	23,994	38,951	16,649
Net Cash Growth	-55.61%	-38.40%	133.95%	-
Net Cash Per Share	428.71	1019.11	1746.78	746.98
Filing Date Shares Outstanding	26.88	26.88	22.3	22.3
Total Common Shares Outstanding	26.88	26.88	23.34	22.3
Working Capital	5,024	15,395	56,656	19,379
Book Value Per Share	1659.62	2016.16	2607.28	2348.53
Tangible Book Value	43,088	54,158	60,784	52,332
Tangible Book Value Per Share	1602.88	2014.69	2604.66	2346.83
Land	2,115	1,787	1,787	1,922
Buildings	4,123	3,215	3,046	3,388
Machinery	1,333	1,268	1,196	1,101

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.